{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T14:26:55Z","timestamp":1773671215730,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T00:00:00Z","timestamp":1731196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Reports"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.toxrep.2024.101809","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T21:18:40Z","timestamp":1731705520000},"page":"101809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Phenobarbital use in pediatric perampanel overdose with coma, respiratory compromise"],"prefix":"10.1016","volume":"13","author":[{"given":"Adam","family":"Brzezinski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar I.","family":"Menchaca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shashikanth","family":"Gangu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxrep.2024.101809_bib1","unstructured":"FDA. Drugs@FDA: FDA-Approved Drugs. https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&ApplNo=208277 (2019), Accessed 4th Feb 2020."},{"issue":"18","key":"10.1016\/j.toxrep.2024.101809_bib2","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1212\/WNL.0b013e318254473a","article-title":"Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures","volume":"78","author":"Krauss","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.toxrep.2024.101809_bib3","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1528-1167.2011.03109.x","article-title":"Perampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy","volume":"52","author":"Hanada","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.toxrep.2024.101809_bib4","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1177\/0883073819827407","article-title":"Adjunctive perampanel oral suspension in pediatric patients from > 2 to < 12 years of age with epilepsy: pharmacokinetics, safety, tolerability, and efficacy","volume":"34","author":"Renfroe","year":"2019","journal-title":"J. Child Neurol."},{"issue":"7","key":"10.1016\/j.toxrep.2024.101809_bib5","doi-asserted-by":"crossref","first-page":"1545.e1","DOI":"10.1016\/j.ajem.2020.04.039","article-title":"Pediatric perampanel poisoning","volume":"38","author":"Qozi","year":"2020","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.toxrep.2024.101809_bib6","first-page":"1","article-title":"Making a difference for patients with uncontrolled epilepsy","volume":"13","author":"Craig","year":"2013","journal-title":"Adv. Clin. Neurosci. Rehabil."},{"issue":"5","key":"10.1016\/j.toxrep.2024.101809_bib7","article-title":"\"Zombielike\" aggression in perampanel overdose","volume":"13","author":"Morsi","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.toxrep.2024.101809_bib8","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/epi.13054","article-title":"Psychiatric and behavioral adverse events in randomized clinical studies of the noncompetitive AMPA receptor antagonist perampanel","volume":"56","author":"Ettinger","year":"2015","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.toxrep.2024.101809_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-232517","article-title":"Prolonged unconsciousness in perampanel overdose","volume":"12","author":"Parsons","year":"2019","journal-title":"BMJ Case Rep."},{"issue":"2","key":"10.1016\/j.toxrep.2024.101809_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.14581\/jer.18014","article-title":"Prolonged stupor in perampanel overdose and pharmacokinetic considerations","volume":"8","author":"Kim","year":"2018","journal-title":"J. Epilepsy Res."},{"key":"10.1016\/j.toxrep.2024.101809_bib11","unstructured":"Clinical Drug Interaction Studies \u2014 Cytochrome P450 Enzyme- and Transporter-Mediated Drug Interactions Guidance for Industry (January 2020) available at: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/clinical-drug-interaction-studies-cytochrome-p450-enzyme-and-transporter-mediated-drug-interactions."},{"issue":"2","key":"10.1016\/j.toxrep.2024.101809_bib12","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/bcp.12951","article-title":"Impact of perampanel on pharmacokinetics of concomitant antiepileptics in patients with partial-onset seizures: pooled analysis of clinical trials","volume":"82","author":"Majid","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.toxrep.2024.101809_bib13","doi-asserted-by":"crossref","unstructured":"Di L., Kerns E.H. Hoboken, N.J.: John Wiley & Sons; 2015. Blood-brain Barrier in Drug Discovery: Optimizing Brain Exposure of CNS Drugs and Minimizing Brain Side Effects for Peripheral Drugs.","DOI":"10.1002\/9781118788523"},{"issue":"4","key":"10.1016\/j.toxrep.2024.101809_bib14","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2014.891580","article-title":"The discovery and development of perampanel for the treatment of epilepsy","volume":"9","author":"Hanada","year":"2014","journal-title":"Expert Opin. Drug Discov."},{"issue":"3","key":"10.1016\/j.toxrep.2024.101809_bib15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1084\/jem.20071474","article-title":"Glutamate mediates platelet activation through the AMPA receptor","volume":"205","author":"Morrell","year":"2008","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.toxrep.2024.101809_bib16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.psym.2018.07.002","article-title":"Severe aggression after perampanel overdose: case report","volume":"60","author":"Wu","year":"2019","journal-title":"Psychosomatics"}],"container-title":["Toxicology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750024001926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750024001926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T12:08:29Z","timestamp":1735301309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214750024001926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":16,"alternative-id":["S2214750024001926"],"URL":"https:\/\/doi.org\/10.1016\/j.toxrep.2024.101809","relation":{},"ISSN":["2214-7500"],"issn-type":[{"value":"2214-7500","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenobarbital use in pediatric perampanel overdose with coma, respiratory compromise","name":"articletitle","label":"Article Title"},{"value":"Toxicology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxrep.2024.101809","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101809"}}